Plant ID: NPO22043
Plant Latin Name: Hylomecon japonica
Taxonomy Genus: Hylomecon
Taxonomy Family: Papaveraceae
NCBI TaxonomyDB:
72187
Plant-of-the-World-Online:
n.a.
China
MTOR; | |
TP53; | |
SLC10A1; | |
SMN1;SMN2; | |
THPO; LMNA; RAD52; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
SLC superfamily of solute carriers | SLC10A1 | Bile acid transporter | Q14973 | CHEMBL5287 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | RAD52 | DNA repair protein RAD52 homolog | P43351 | CHEMBL2362978 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.745E-09 | 5.978E-05 | CYP1A2, CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.924E-06 | 2.095E-02 | CYP1A2, CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 6.182E-06 | 3.365E-02 | CYP1A2, CYP2D6 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.940E-05 | 3.382E-02 | CYP1A2, CYP2C19 |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 2.425E-05 | 3.382E-02 | LMNA, MTOR, TP53 |
MF | GO:0003824; catalytic activity | GO:0004497; monooxygenase activity | 1.848E-05 | 3.382E-02 | CYP1A2, CYP2C19, CYP2D6 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 1.940E-05 | 3.382E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 2.292E-05 | 3.382E-02 | SMN1, SMN2 |
MF | GO:0005488; binding | GO:0020037; heme binding | 4.511E-05 | 4.093E-02 | CYP1A2, CYP2C19, CYP2D6 |
CC | GO:0044464; cell part | GO:0034719; SMN-Sm protein complex | 4.489E-05 | 4.093E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 6.357E-06 | 4.323E-04 | CYP2D6, CYP1A2, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 5.613E-04 | 9.622E-03 | TP53, MTOR |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.108E-04 | 3.766E-03 | CYP1A2, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 5.963E-04 | 9.622E-03 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 1.049E-03 | 9.940E-03 | TP53, MTOR |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 7.075E-04 | 9.622E-03 | CYP2D6, CYP1A2 |
09150 Organismal Systems | 09149 Aging | hsa04211 | Longevity regulating pathway - mammal | 1.169E-03 | 9.940E-03 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 8.917E-04 | 9.940E-03 | CYP1A2, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.654E-03 | 1.247E-02 | CYP2D6, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 1.833E-03 | 1.247E-02 | TP53, MTOR |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |